Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01658670 · ClinicalTrials.gov registry record · NA
HEART Camp: Promoting Adherence to Exercise in Patients With Heart Failure
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 245
- Enrollment target
NCT01658670: Completed NA study, sponsored by University of Nebraska.
NCT01658670 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 245 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01658670, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 245 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy of the Heart Failure Exercise and Resistance Training (HEART) Camp behavioral exercise training intervention on long-term adherence to exercise at 18 months in patients with heart failure. The central hypothesis is that the HEART Camp intervention group (HC) will have significantly better adherence to exercise at 18 months.
Primary Outcome
Adherence to exercise with 18 months as the primary outcome time point.
Interventions
- BEHAVIORAL Enhanced Usual Care Group
- BEHAVIORAL HEART Camp (HC) Intervention Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 245 participants |
| Start Date | 2012-04-01 |
| Est. Completion | 2018-03-01 |
| Phase | NA |
What the finished NCT01658670 record still lists
NCT01658670 is an interventional study that assigns participants to a tested intervention. The registered 245 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which Enhanced Usual Care Group is the first listed.
NCT01658670 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01658670 about?
NCT01658670 is a clinical study titled "HEART Camp: Promoting Adherence to Exercise in Patients With Heart Failure". The purpose of this study is to determine the efficacy of the Heart Failure Exercise and Resistance Training (HEART) Camp behavioral exercise training intervention on long-term adherence to exercise at 18 months in patients with heart failure. The central hypothesis is that the HEART Camp interventi...
What is the current status of trial NCT01658670?
This trial is currently completed. It is a NA study. The enrollment target is 245 participants. The study started on 2012-04-01. Estimated completion is 2018-03-01.
What interventions are being tested in trial NCT01658670?
The interventions under investigation include: Enhanced Usual Care Group (BEHAVIORAL), HEART Camp (HC) Intervention Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT01658670?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01658670's enrollment target sits among peer trials
245 436th of 2000 higher than 1,563 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03645928 · 245 participants · Phase 2
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
- NCT04718168 · 245 participants · NA
GORE® ENFORM Biomaterial Product Study
- NCT05145127 · 245 participants · Phase 3
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- NCT05446259 · 245 participants
Degenerative Cervical Myelopathy Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI